MacroGenics, based in Rockville, Md., announced its acquisition of RavenBiotechnologies, based in San Francisco. Both biotechnology companies focus on treatment development of cancer and immune system-related therapeutics and are heavily venture backed. Company Web site
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.